⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRCE News
Grace Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
GRCE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
accessnewswire.com
GRCE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
accessnewswire.com
GRCE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
accessnewswire.com
GRCE
Form 8-K
sec.gov
GRCE
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
globenewswire.com
GRCE
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
globenewswire.com
GRCE
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
globenewswire.com
GRCE
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
GRCE
Business-to-Business (B2B) Continuing Education Report 2026: A $10+ Billion Market by 2030, Driven by Rising Demand for Online Learning, AI Personalization, and Reskilling Programs - Forecast to 2035
globenewswire.com
ACN
NU
MSFT
ORCL
ADBE
WLY
COUR
SKIL
HSTM
GDEN
DLB
LTRX
SONO
GRCE